Loading...
Amyloid-β (11)C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
OBJECTIVE: To evaluate the effects of bapineuzumab on brain β-amyloid (Aβ) burden using (11)C-Pittsburgh compound B ((11)C-PiB)-PET. METHODS: Two phase 3 clinical trials, 1 each in apolipoprotein APOE ε4 carriers and noncarriers, were conducted in patients with mild to moderate Alzheimer disease dem...
Na minha lista:
| Udgivet i: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4553028/ https://ncbi.nlm.nih.gov/pubmed/26208959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001877 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|